Evidence map›Paper›PMID 40281469›Full record

ArticleBMC pregnancy and childbirth2025

Development of an intervention for smoking cessation in pregnant women using a theory-based approach.

Estelle Clet, Adrianna Burtin, Nolwenn Stevens, Charlotte Kervran, Rebecca Ratel, Manon Vergneau, Perrine Moysan, Manon Frevol, Loïc Sentilhes, Philippe Castera and 2 more

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Estelle CletDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France. estelle.clet@chu-bordeaux.fr.
Adrianna BurtinDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France.
Nolwenn StevensDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France.
Charlotte KervranInserm, UMR 1219, University of Bordeaux, Bordeaux Population Health, 12 Rue Dubernat, Bordeaux, 33000, France.
Rebecca RatelDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France.
Manon VergneauInserm, UMR 1219, University of Bordeaux, Bordeaux Population Health, 12 Rue Dubernat, Bordeaux, 33000, France.
Perrine MoysanInserm, UMR 1219, University of Bordeaux, Bordeaux Population Health, 12 Rue Dubernat, Bordeaux, 33000, France.
Manon FrevolDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France.
Loïc SentilhesDepartment of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France.
Philippe CasteraDepartment of General Practice, University of Bordeaux, Bordeaux, France.
François AllaDepartment of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France.
5A-QUIT-N groupx

Funding

Agence Régionale de Santé Nouvelle-Aquitaine FIR 2019Direction Générale de l'offre de Soins PREPS 2019Institut National du Cancer et Institut de Recherche en Santé Publique INCa-IReSP TABAC 2019
6 · The paper itself

Abstract

backgroundWhile the global prevalence of smoking during pregnancy is 1.7%, it rises to 8.1% in Europe, where it is the main modifiable risk factor for morbidity and mortality during pregnancy. However, pregnancy is a key time to implement smoking cessation interventions, as women are more likely to adopt health-promoting behaviours during this period. Despite the availability of resources (e.g. policies, tools) and strategies (e.g. nicotine replacement therapy) to address smoking, their implementation remains neither optimal nor systematic. To address this, a multi-disciplinary multi-professional team developed the 5A-QUIT-N intervention to promote smoking cessation in pregnant women, by mobilising health professionals and optimising existing resources. Rather than creating new resources, the intervention uses existing tools and strategies and better integrates them into the pregnancy monitoring process. This article describes the development and operationalisation of the 5A-QUIT-N intervention.

methodsThe development of the 5A-QUIT-N intervention involved three stages. First, its components were established according to national recommendations and a final list was validated by a scientific committee. Next, obstacles and levers that could influence their implementation and effectiveness were identified through a scoping review and semi-structured interviews. The resulting data were then used to design the first version of the intervention.

resultsFindings from the literature and field experiences highlighted the need for better mobilisation and coordination of the existing resources. The 5A-QUIT-N intervention was developed to address these issues by improving resource organisation within each region. At the clinical level, it aims to enhance healthcare professionals' skills in smoking cessation practices using existing resources. At the organisational level, it promotes closer coordination between perinatal and smoking cessation professionals. The involvement of local stakeholders and local resources is an integral part of the intervention, as these vary from one region to another.

conclusionThis intervention was made possible thanks to the combination of a literature search, a qualitative study, and commitment from stakeholders from grassroots level upwards.

Indexed as

Health PromotionPregnancy ComplicationsPregnant PeoplePrenatal CareSmoking CessationFemaleHumansPregnancyProgram DevelopmentEvidence-based health promotionHealth promotionInnovationPregnancySmoking cessationTheory-basedTobacco

Identifiers

PMID40281469
PMCPMC12023484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.